Periodontology

According to the Fourth German Oral Health Study (DMS IV), since 1997, the number of adults and seniors suffering from periodontal disease has risen by about 26.9 and 23.7 percent, respectively.  Among adults, 52.7 percent suffer from moderately severe periodontitis, while 20.5 percent suffer from an acute case of the disease. Among seniors, 48 percent suffer from moderately severe periodontitis, while 39.8 percent are severely affected by the disease. According to the Guinness Book of World Records 2001, periodontitis is the world’s number one widespread disease.

In the area of periodontology, an aMMP-8 early detection test enables prompt monitoring of treatment success. It documents the status before treatment and verifies the success of treatment after just two to three weeks.

The test can also be used for the early detection of any flare-up of tissue destruction. At-risk patients should be given the test twice a year as part of the routine check-ups. This is particularly important when refractory progression of the disease is suspected. In that case, one must demonstrate that the patient is free of inflammation prior to undertaking regenerative measures in the periodontium such as membranes, enamel matrix proteins or bone replacement materials. The test can be integrated into the practice’s check-up system to provide successful prevention, screening and monitoring of periodontitis.

An aMMP-8 early detection test measures the onset of enzyme activity –  a simple and sure way to diagnose an inflammation.